UGA study questions effectiveness of US FDA Alzheimer's drug

The effectiveness of a new drug used to treat Alzheimer’s was called into question by a recent University of Georgia study, according to a Jan. 22 press release.

Related Keywords

United States , Americans , Kanishka Baduni , Gabrielle Grasso , Henryc Barry , Mark Ebell , College Of Public Health , University Of Georgia , Department Of Kineseology , Drug Administration , Michigan State University College Of Human Medicine , Mary Frances Early College Of Education , Public Health , Mini Mental State , Important Benefits , Monoclonal Antibodies Targeting Amyloid , Alzheimer Disease , Systematic Review , Michigan State University , Human Medicine , Mary Frances Early College , Uga , Thens Georgia , Nga Research , Ga Study , Ga Researchers , Alzheimers , Medicine , Harmacology , Sychology , Rade , Ociology , Statistics , Ournalism , Philosophy , Chemistry ,